World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
20706
World Ranking
2569
National Ranking
193

Schlomo Staszewski publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Schlomo Staszewski sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 176 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Schlomo Staszewski D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Schlomo Staszewski sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Schlomo Staszewski is affiliated with Goethe University Frankfurt in Germany. Their research focuses primarily on medicine, with particular emphasis on infectious diseases and virology. The scientist's academic contributions span topics related to HIV research and treatment, including HIV/AIDS research and interventions as well as drug development for HIV/AIDS.

The scientist's work has been published in several venues, with notable contributions to the Journal of Antimicrobial Chemotherapy. Among their recent publications is the 2021 paper titled "2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings", published in the Journal of Antimicrobial Chemotherapy.

Frequent co-authors collaborating with Schlomo Staszewski include:

  • Carlo Torti
  • Robin Wood
  • Dolphina Cogill
  • Hugo Tempelman
  • Raph L Hamers

These collaborations indicate a research network involved in infectious disease and HIV-related studies, integrating expertise from multiple researchers. The scientist's publication record aligns closely with their disciplinary focuses on immunology, microbiology, and infectious diseases.

Best Publications

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.

    Joel E. Gallant;Schlomo Staszewski;Anton L. Pozniak;Edwin DeJesus

  • Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

    R Hogg;V Lima;J Sterne;S Grabar

  • Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

    Schlomo Staszewski;Javier Morales-Ramirez;Karen T. Tashima;Anita Rachlis

  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

    Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  • A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

    Kurt Hertogs;Marie-Pierre de Béthune;Veronica Miller;Tania Ivens

  • Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

    Gerd Fätkenheuer;Anton L Pozniak;Margaret A Johnson;Andreas Plettenberg

  • The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

    Joseph Eron;Patrick Yeni;Joseph Gathe;Vicente Estrada

  • HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

    Andrew N. Phillips;Schlomo Staszewski;Rainer Weber;Ole Kirk

  • Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

    Schlomo Staszewski;Philip Keiser;Julio Montaner;Francois Raffi

  • Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.

    G Chêne;J A C Sterne;M May;D Costagliola

  • HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

    May Mt;Sterne Ja;Costagliola D;Sabin Ca

  • Chronic renal failure among HIV-1-infected patients

    Amanda Mocroft;Ole Kirk;Jose Gatell;Peter Reiss

  • Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

    Veronica Miller;Caroline Sabin;Kurt Hertogs;Stuart Bloor

  • Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America

    E. Girardi;C.A. Sabin;A. d'Arminio Monforte;B. Hogg

  • Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.

    M.W. Lorenz;C. Stephan;A. Harmjanz;S. Staszewski

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

    K. Hertogs;S. Bloor;S. D. Kemp;C. van den Eynde

  • Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naïve HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study

    Hassane Izzedine;Jean Sebastien Hulot;Daniel Vittecoq;Joel E. Gallant

  • Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients : A randomized controlled comparison with zidovudine monotherapy

    Christine Katlama;Didier Ingrand;Clive Loveday;Nathan Clumeck

Frequent Co-Authors

Andrew N. Phillips
Andrew N. Phillips University College London
Veronica Miller
Veronica Miller University of California, Berkeley
Caroline Sabin
Caroline Sabin University College London
Christine Katlama
Christine Katlama Sorbonne University
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Gerd Fätkenheuer
Gerd Fätkenheuer University of Cologne
Margaret Johnson
Margaret Johnson The Royal Free Hospital
Peter Reiss
Peter Reiss University of Amsterdam
José M. Gatell
José M. Gatell University of Barcelona
Bruno Ledergerber
Bruno Ledergerber University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various healthcare and biomedical fields, many of which now offer flexible online programs. For those interested in blending healthcare with information technology, pursuing an online cahiim accredited health information management degree can provide essential skills to manage patient data securely and efficiently.

Career prospects in health information management are promising, with competitive health information manager salary packages reflecting the critical role these professionals play in healthcare systems. Alternatively, students seeking quicker entry into the medical administration field might consider an medical billing and coding certificate online accelerated program, which offers streamlined training for essential medical billing skills.

For those exploring broader medical education options, it's worth researching what medical degree can i get online, as online pathways continue to expand in scope and availability, making healthcare education more accessible than ever.

Overall, these related online degrees complement a background in microbiology by equipping students with versatile skills in healthcare data management, administration, and clinical knowledge, paving the way for diverse career pathways.

Best Scientists Citing Schlomo Staszewski

Trending Scientists

Recently Published Articles